Match!

Tissue proteomics for cancer biomarker development: laser microdissection and 2D-DIGE.

Published on Sep 30, 2008in Journal of Biochemistry and Molecular Biology
· DOI :10.5483/BMBRep.2008.41.9.626
Tadashi Kondo1
Estimated H-index: 1
Abstract
Novel cancer biomarkers are required to achieve early diagnosis and optimized therapy for individual patients. Cancer is a disease of the genome, and tumor tissues are a rich source of cancer biomarkers as they contain the functional translation of the genome, namely the proteome. Investigation of the tumor tissue proteome allows the identification of proteomic signatures corresponding to clinico-pathological parameters, and individual proteins in such signatures will be good biomarker candidates. Tumor tissues are also a rich source for plasma biomarkers, because proteins released from tumor tissues may be more cancer specific than those from non-tumor cells. Two-dimensional difference gel electrophoresis (2D-DIGE) with novel ultra high sensitive fluorescent dyes (CyDye DIGE Fluor satulation dye) enables the efficient protein expression profiling of laser-microdissected tissue samples. The combined use of laser microdissection allows accurate proteomic profiling of specific cells in tumor tissues. To develop clinical applications using the identified biomarkers, collaboration between research scientists, clinicians and diagnostic companies is essential, particularly in the early phases of the biomarker development projects. The proteomics modalities currently available have the potential to lead to the development of clinical applications, and channeling the wealth of produced information towards concrete and specific clinical purposes is urgent. [BMB reports 2008; 41(9): 626-634] Biomarkers for better clinical outcome of cancer patients
  • References (56)
  • Citations (34)
📖 Papers frequently viewed together
3,396 Citations
4,239 Citations
1,860 Citations
78% of Scinapse members use related papers. After signing in, all features are FREE.
References56
Newest
#1Shigeru SaitoH-Index: 70
#2Hidenori OjimaH-Index: 34
Last. Tadashi KondoH-Index: 31
view all 5 authors...
α-Fetoprotein (AFP) is considered to be a diagnostic and prognostic biomarker in hepatocellular carcinoma (HCC). However, the role of AFP in the development of HCC is presently obscure. We hypothesized that a certain set of genes is expressed in a manner coordinate with AFP, and that these genes essentially contribute to the malignant characteristics of AFP-producing HCC. To address this hypothesis, we carried out global mRNA expression analysis of 21 liver cancer cell lines that produce varying...
18 CitationsSource
#1Tomoya Fukui (Kitasato University)H-Index: 14
#2Yuichiro OheH-Index: 49
Last. Tomohide TamuraH-Index: 57
view all 17 authors...
Purpose: Epidermal growth factor receptor ( EGFR ) mutations, especially in-frame deletions in exon 19 (DEL) and a point mutation in exon 21 (L858R), predict gefitinib sensitivity in patients with non–small cell lung cancer (NSCLC). In this study, we verified the accuracy of EGFR mutation analysis in small samples by high-resolution melting analysis (HRMA), which is a rapid method using PCR amplification with a dye to analyze the melting curves in NSCLC. Experimental Design: We designed a prospe...
70 CitationsSource
#1Yoshiyuki SueharaH-Index: 16
#2Tadashi KondoH-Index: 31
Last. Setsuo HirohashiH-Index: 99
view all 14 authors...
Purpose: We aimed to develop prognostic biomarkers for gastrointestinal stromal tumors (GIST) using a proteomic approach. Experimental Design: We examined the proteomic profile of GISTs using two-dimensional difference gel electrophoresis. The prognostic performance of biomarker candidates was examined using a large-scale sample set and specific antibodies. Results: We identified 43 protein spots whose intensity was statistically different between GISTs with good and poor prognosis. Mass spectro...
72 CitationsSource
#1Barbara MroczkoH-Index: 28
#2Miroslaw KozlowskiH-Index: 18
Last. Maciej SzmitkowskiH-Index: 26
view all 9 authors...
Abstract Background Matrix metalloproteinases (MMPs) are zinc-dependent endopeptidases associated with tumor progression. It was proved that expression of MMP-9 in human esophageal cancer tissues correlated with stages of the disease. The aim of the present study was to determine potential clinical use of serum MMP-9 as a tumor marker of esophageal cancer. Methods The study included 89 patients with esophageal cancer and 30 healthy subjects (control group). We assayed serum levels of MMP-9 and c...
56 CitationsSource
#1Sophia Hober (KTH: Royal Institute of Technology)H-Index: 36
#2Mathias Uhlén (KTH: Royal Institute of Technology)H-Index: 93
Currently one of the most challenging tasks in biological and medical research is to explore and understand the function of all proteins encoded by the genome of an organism. A systematic approach based on the genome sequences is feasible because the full genome of many organisms presently is available and many more are underway. For the production of expression atlases different strategies are used. Early attempts to acquire information about protein expression levels have focused on the analys...
45 CitationsSource
#1Tatsuhiko Kakisaka (Hokkaido University)H-Index: 10
#2Tadashi KondoH-Index: 31
Last. Setsuo HirohashiH-Index: 99
view all 15 authors...
We investigated the aberrant expression of plasma proteins in patients with pancreatic cancer. High-abundance plasma proteins (albumin, transferrin, haptoglobin, alpha-1-antitrypsin, IgG and IgA) were depleted by use of an immuno-affinity column, and low-abundance ones were separated into five fractions by anion-exchange chromatography. The fractionated plasma proteins were subjected to 2D-DIGE with highly sensitive fluorescent dyes. The quantitative protein expression profiles obtained by 2D-DI...
82 CitationsSource
#1Bengt Nilsson (University of Gothenburg)H-Index: 22
#2Katarina Sjölund (University of Gothenburg)H-Index: 4
Last. Håkan Ahlman (University of Gothenburg)H-Index: 48
view all 8 authors...
Palliative imatinib treatment has dramatically improved survival in patients with malignant gastrointestinal stromal tumours, particularly in patients with tumours harbouring activating KIT mutations. To evaluate the effectiveness of adjuvant imatinib after radical surgery, a consecutive series of patients with high-risk tumours (n=23) was compared with historic controls (n=48) who were treated with surgery alone. The mean follow-up period was over 3 years in both groups. Only 1 out of 23 patien...
111 CitationsSource
#1Hideki Yokoo (Hokkaido University)H-Index: 20
#2Tadashi KondoH-Index: 31
Last. Setsuo HirohashiH-Index: 99
view all 8 authors...
The poor prognosis of patients with hepatocellular carcinoma (HCC) is attributed to intrahepatic recurrence. To understand the molecular background of early intrahepatic recurrence, we conducted a global protein expression study. We compared the protein expression profiles of the primary HCC tissues of 12 patients who showed intrahepatic recurrence within 6 months post surgery with those of 15 patients who had no recurrence 2 years post surgery. Two-dimensional difference gel electrophoresis ide...
17 CitationsSource
#1Changsong ZhangH-Index: 7
#2ZhengyouLiH-Index: 2
Last. Lixin WeiH-Index: 32
view all 8 authors...
Purpose: CpG island methylator phenotype (CIMP) involves hypermethylation targeted toward the promoters of multiple genes. To gain insight into the role of epigenetic aberration of tumor-related genes in hepatocarcinogenesis, we determined a hypermethylation profile in hepatocellular carcinoma (HCC). Experimental Design: We examined the promoter methylation status of nine genes in 50 HCCs, 50 paired nontumor tissues, and 6 normal liver tissues by methylation-specific PCR. CIMP+ was defined as ha...
49 CitationsSource
#1Tetsuya OkanoH-Index: 17
#2Tadashi KondoH-Index: 31
Last. Setsuo HirohashiH-Index: 99
view all 12 authors...
Purpose: We aimed to identify candidate proteins for tumor markers to predict the response to gefitinib treatment. Experimental Design: We did two-dimensional difference gel electrophoresis to create the protein expression profile of lung adenocarcinoma tissues from patients who showed a different response to gefitinib treatment. We used a support vector machine algorithm to select the proteins that best distinguished 31 responders from 16 nonresponders. The prediction performance of the selecte...
56 CitationsSource
Cited By34
Newest
#1Akinori Ishihara (Shizuoka University)H-Index: 10
Last. Kiyoshi Yamauchi (Shizuoka University)H-Index: 20
view all 8 authors...
Abstract Techniques for analyzing genome-wide expression profiles, such as the microarray technique and next-generation sequencers, have been developed. While these techniques can provide a lot of information about gene expression, selection of genes of interest is complicated because of excessive gene expression data. Thus, many researchers use statistical methods or fold change as screening tools for finding gene sets whose expression is altered between groups, which may result in the loss of ...
Source
#1Olga M. Ivanova (RAS: Russian Academy of Sciences)H-Index: 3
#2Rustam H. Ziganshin (RAS: Russian Academy of Sciences)H-Index: 14
Last. Vadim T. Ivanov (RAS: Russian Academy of Sciences)H-Index: 32
view all 9 authors...
Serum samples (33 healthy women, 34 ovarian cancer, 28 colorectal cancer, 34 syphilis patients and 136 patients with various benign gynecological diseases) were analyzed by MALDI-TOF MS peptide profiling and respective predictive models were generated by genetic and supervised neural network algorithms. Classification models for pathology versus healthy control showed up to 100% sensitivity and specificity for all target diseases. However, the specificity dropped to unsatisfactory 25–40% in case...
Source
#1Cordelia Geisler (RWTH Aachen University)H-Index: 5
#2Nadine T. Gaisa (RWTH Aachen University)H-Index: 12
Last. Corinna Henkel (RWTH Aachen University)H-Index: 13
view all 15 authors...
This study was designed to identify and validate potential new biomarkers for prostate cancer and to distinguish patients with and without biochemical relapse. Prostate tissue samples analyzed by 2D-DIGE (two-dimensional difference in gel electrophoresis) and mass spectrometry (MS) revealed downregulation of secernin-1 ( < 0.044) in prostate cancer, while vinculin showed significant upregulation ( < 0.001). Secernin-1 overexpression in prostate tissue was validated using Western blot and immunoh...
16 CitationsSource
#1Qihui Wang (Sichuan University)H-Index: 4
#2Qiaoling Yu (Sichuan University)H-Index: 3
Last. Yixiang Duan (Sichuan University)H-Index: 24
view all 4 authors...
Abstract Human saliva, a multi-constituent oral fluid, has a high potential for early diagnosis of disease. Proteomic analysis of saliva holds promise as a non-invasive method that is advantageous over serum. This non-invasive diagnostic method represents developing trends in analytical and clinical chemistry. Significant technological advances in the field of proteomics during the last two decades have greatly facilitated the research toward this direction. However, these technologies still req...
20 CitationsSource
#1Hadi MohammadiH-Index: 11
Last. Guy FradetH-Index: 25
view all 3 authors...
St. Jude Medical (SJM) bileaflet mechanical valves were approved by the Food and Drug Administration in 1977. The SJM valve design consists of two semicircular leaflets which pivot on hinges. Compared to other mechanical heart valve prostheses such as ball and cage and tilting disk prosthetic valves, it provides good central flow, the leaflets open completely, and the pressure drop across the valve is trivial. However, non-physiological hemodynamics around these valves may lead to red blood cell...
#1Maria P. PavlouH-Index: 11
1 Citations
#1Pavel Gromov (The Breast Cancer Research Foundation)H-Index: 32
#2Jose Ma Moreira (UCPH: University of Copenhagen)H-Index: 2
Last. Irina Gromova (The Breast Cancer Research Foundation)H-Index: 34
view all 3 authors...
In the last decade, many proteomic technologies have been applied, with varying success, to the study of tissue samples of breast carcinoma for protein expression profiling in order to discover protein biomarkers/signatures suitable for: characterization and subtyping of tumors; early diagnosis, and both prognosis and prediction of outcome of chemotherapy. The purpose of this review is to critically appraise what has been achieved to date using proteomic technologies and to bring forward novel s...
8 CitationsSource
Source
#1Andrei P. Drabovich (MSH: Mount Sinai Hospital, Toronto)H-Index: 22
#2Maria P. Pavlou (U of T: University of Toronto)H-Index: 11
Last. Eleftherios P. DiamandisH-Index: 99
view all 4 authors...
Protein biomarker discovery is a multiphase process that includes biomarker candidate identification, verification, and validation. In this chapter, we review proteomic samples and methods used at each phase of the protein biomarker discovery and development pipeline and focus on mass spectrometry as a key technique for qualitative and quantitative analysis of proteins. Details on proteomic sample preparation protocols, protein identification and quantification approaches, post-translational mod...
16 CitationsSource